Michael Krainer

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

Eugene D. Kwon, Charles G. Drake, H. I. Scher et al. · The Lancet Oncology · 2014 · 1.5K citations · Full text

Urology, Oncology, Docetaxel Chemotherapy +9

Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome

Kim E. Nichols, D. Paul Harkin, Seth Levitz et al. · Proceedings of the National Academy of Sciences · 1998 · 495 citations · Full text

Germ-Line<i>BRCA1</i>Mutations in Jewish and Non-Jewish Women with Early-Onset Breast Cancer

Michael G. FitzGerald, Deborah J. MacDonald, Michael Krainer et al. · New England Journal of Medicine · 1996 · 387 citations · Full text

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1

Matthew R. Smith, Johann S. de Bono, Cora N. Sternberg et al. · Journal of Clinical Oncology · 2016 · 244 citations

Differential Contributions of<i>BRCA1</i>and<i>BRCA2</i>to Early-Onset Breast Cancer

Michael Krainer, Sandra Silva-Arrieta, Michael G. FitzGerald et al. · New England Journal of Medicine · 1997 · 210 citations · Full text